Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04514016
  4. Details
NCT04514016 Clinical Trial

Cross Sectional CFAR HIV/COVID-19 Study

Covid19 Clinical Trial

Official title:
Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04514016
Other study ID # 20200802
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 12, 2020
Est. completion date March 17, 2021

Study information
Verified date March 2021
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected children, adolescents, and youth receiving their primary HIV care at the University of Miami Miller School of Medicine.

Recruitment information / eligibility
Status Completed
Enrollment 64
Est. completion date March 17, 2021
Est. primary completion date March 17, 2021
Accepts healthy volunteers
Gender All
Age group 3 Years to 25 Years
Eligibility Inclusion Criteria: - Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children Research Institute (BCRI) - Being diagnosed with HIV infection by the time of enrollment - At enrollment, 3 to < 26 years Exclusion Criteria: - Patient will be excluded from the study if any of the following are identified: - Patients under legal age and in the State's custody - Participant or legal guardian unable to sign Informed Consent forms - Participant unable to complete study visits

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Batchelor's Children's Research Institute Miami Florida

Sponsors (2)
Lead Sponsor Collaborator
University of Miami Miami Center for AIDS Research (CFAR)

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of participants who tested positive with SARS COV-2 Infection SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay month 3
Primary Number of participants who tested positive with SARS COV-2 antibody SARS COV-2 antibody will be analyzed from blood samples via serological assay month 3
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3